menu close
www.parallel.bio

Parallel Bio Stock

Company Profile:

Parallel Bio develops a biotech platform that replicates the human immune system using organoid technology and automation to design and test immunotherapies in vitro. By combining immune organoids with AI-driven analytics, it enables scalable, human-relevant modeling to accelerate drug discovery and improve the prediction of therapy safety and effectiveness.

Sign up for SecondMarket® to view the market and buy or sell Parallel Bio Stock
Buy + Sell

Parallel Bio Funding

Sign up to gain insights into Parallel Bio funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Jun 12, 2025 Series A 21.00M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D®

Leverage Your Equity to Help Achieve More.

Parallel Bio Management Team

  • Co-Founder

    Juliana L. Hilliard

  • Co-Founder

    Robert M. DiFazio

Parallel Bio Major Investors

  • Metaplanet Holdings

  • Undeterred Capital

  • Atypical Ventures

  • Amplo

  • AIX Ventures

  • Humba Ventures

Learn More About Parallel Bio Stock

Buy Parallel Bio Stock
01

Parallel Bio stock does not trade on public stock exchanges. Parallel Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Parallel Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Parallel Bio Stock
02

Parallel Bio Stock does not trade on public stock exchanges. In order to sell Parallel Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Parallel Bio Stock Price
03

Parallel Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Parallel Bio share price and other valuable private market data.

Read more about secondary market private company stock prices:

Parallel Bio Stock Ticker Symbol
04

There is no ticker symbol for Parallel Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Parallel Bio Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Parallel Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Parallel Bio Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Parallel Bio stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Parallel Bio Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Parallel Bio IPO
08

Parallel Bio is a private company and has not had an IPO. There is currently no Parallel Bio IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Parallel Bio IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Parallel Bio Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Cityblock Health-Logo

Cityblock Health

Tech-driven care provider for communities with complex needs.

Lyra Healthcare-Logo

Lyra

Digital health startup using technology to connect companies and employees to mental health providers.

Cedar Inc-Logo

Cedar

The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.

Devoted-Logo

Devoted

Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

Cerebral

Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

Hinge Health-Logo

Hinge Health

Digital clinic for back, joint, and muscle pain.

Somatus-Logo

Somatus

Integrated care for patients with or at risk of developing kidney disease.

Human Longevity Inc.-Logo

Human Longevity

Healthcare technology for genomic sciences.

Freenome-Logo

Freenome

Health technology company using non-invasive disease screenings to treat diseases.

Source: Nasdaq Private Market Tape D®